FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012080421> ?p ?o ?g. }

• W2012080421 endingPage "4997" @default.
• W2012080421 startingPage "4991" @default.
• W2012080421 abstract "Leishmune is the industrialized version of the FML-saponin vaccine which has been shown to develop 92-95% protection in vaccinated dogs and 76-80% vaccine efficacy against field canine visceral leishmaniasis (CVL) in Brazil. Leishmune has been proven to be safe and tolerable and a transmission-blocking vaccine which renders vaccinated dogs non-infectious to sand fly vectors. In the present investigation, 550 healthy seronegative dogs of endemic and epidemic areas of Brazil were monitored for Leishmune-induced immunogenicity during a 2-year trial. Another group of 588 untreated exposed dogs was also studied in parallel. Both groups were seronegative on day 0. The strong immunogenicity induced by Leishmune vaccine was demonstrated by the 98% of FML-seroconversion, increase in absorbencies, the 82.7% DTH positive reactions and increase in skin test size diameters, the average increase in CD8+ total lymphocytes population in blood (27.1%), expected for QS21 saponin-containing vaccine, the sustained proportions of CD4+ T cells, and the average increased proportions of CD21+ B lymphocytes (42.3%). The Leishmune-induced protection against CVL is demonstrated by the results: 98.8% asymptomatic dogs (at the end of first year) and 99% healthy survivors (at the end of the second year) among vaccinated dogs, compared to the 79.4% asymptomatic and 61% survivor dogs (p<0.001) monitored in the untreated exposed cohort. In spite of the low vaccine coverage, it was possible to detect a 66.1% (p<0.005) reduction in Belo Horizonte and an 80.2% (p<0.005) reduction in Araçatuba of the incidence of CVL among vaccinated dogs, when compared to the global incidence of CVL of each town, respectively. Our preliminary results support the potential use of Leishmune to prevent CVL epidemics." @default.
• W2012080421 created "2016-06-24" @default.
• W2012080421 creator A5001148074 @default.
• W2012080421 creator A5008710671 @default.
• W2012080421 creator A5033114483 @default.
• W2012080421 creator A5037945835 @default.
• W2012080421 creator A5048943948 @default.
• W2012080421 creator A5059045967 @default.
• W2012080421 creator A5076869850 @default.
• W2012080421 creator A5083040884 @default.
• W2012080421 creator A5087775439 @default.
• W2012080421 date "2008-09-01" @default.
• W2012080421 modified "2023-09-26" @default.
• W2012080421 title "Immunogenicity assay of the Leishmune® vaccine against canine visceral leishmaniasis in Brazil" @default.
• W2012080421 cites W116276269 @default.
• W2012080421 cites W1490261874 @default.
• W2012080421 cites W1840052409 @default.
• W2012080421 cites W1882062365 @default.
• W2012080421 cites W1921204067 @default.
• W2012080421 cites W1963105351 @default.
• W2012080421 cites W1967165009 @default.
• W2012080421 cites W1967769777 @default.
• W2012080421 cites W1969819979 @default.
• W2012080421 cites W1974051529 @default.
• W2012080421 cites W1974652725 @default.
• W2012080421 cites W1986161474 @default.
• W2012080421 cites W1993944869 @default.
• W2012080421 cites W2002827850 @default.
• W2012080421 cites W2012172250 @default.
• W2012080421 cites W2016101999 @default.
• W2012080421 cites W2020508488 @default.
• W2012080421 cites W2021712302 @default.
• W2012080421 cites W2026867655 @default.
• W2012080421 cites W2029250525 @default.
• W2012080421 cites W2032056858 @default.
• W2012080421 cites W2050886892 @default.
• W2012080421 cites W2051703773 @default.
• W2012080421 cites W2053293487 @default.
• W2012080421 cites W2059956370 @default.
• W2012080421 cites W2064551230 @default.
• W2012080421 cites W2075501306 @default.
• W2012080421 cites W2077316523 @default.
• W2012080421 cites W2078427852 @default.
• W2012080421 cites W2080951592 @default.
• W2012080421 cites W2093547754 @default.
• W2012080421 cites W2095331802 @default.
• W2012080421 cites W2103080556 @default.
• W2012080421 cites W2103233028 @default.
• W2012080421 cites W2110498124 @default.
• W2012080421 cites W2113874191 @default.
• W2012080421 cites W2115645562 @default.
• W2012080421 cites W2124500686 @default.
• W2012080421 cites W2131863790 @default.
• W2012080421 cites W2137639827 @default.
• W2012080421 cites W2138562734 @default.
• W2012080421 cites W2147048658 @default.
• W2012080421 cites W2148610656 @default.
• W2012080421 cites W2151434103 @default.
• W2012080421 cites W2164465584 @default.
• W2012080421 doi "https://doi.org/10.1016/j.vaccine.2008.07.029" @default.
• W2012080421 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7173152" @default.
• W2012080421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18675868" @default.
• W2012080421 hasPublicationYear "2008" @default.
• W2012080421 type Work @default.
• W2012080421 sameAs 2012080421 @default.
• W2012080421 citedByCount "65" @default.
• W2012080421 countsByYear W20120804212012 @default.
• W2012080421 countsByYear W20120804212013 @default.
• W2012080421 countsByYear W20120804212014 @default.
• W2012080421 countsByYear W20120804212015 @default.
• W2012080421 countsByYear W20120804212016 @default.
• W2012080421 countsByYear W20120804212017 @default.
• W2012080421 countsByYear W20120804212018 @default.
• W2012080421 countsByYear W20120804212019 @default.
• W2012080421 countsByYear W20120804212020 @default.
• W2012080421 countsByYear W20120804212021 @default.
• W2012080421 countsByYear W20120804212022 @default.
• W2012080421 countsByYear W20120804212023 @default.
• W2012080421 crossrefType "journal-article" @default.
• W2012080421 hasAuthorship W2012080421A5001148074 @default.
• W2012080421 hasAuthorship W2012080421A5008710671 @default.
• W2012080421 hasAuthorship W2012080421A5033114483 @default.
• W2012080421 hasAuthorship W2012080421A5037945835 @default.
• W2012080421 hasAuthorship W2012080421A5048943948 @default.
• W2012080421 hasAuthorship W2012080421A5059045967 @default.
• W2012080421 hasAuthorship W2012080421A5076869850 @default.
• W2012080421 hasAuthorship W2012080421A5083040884 @default.
• W2012080421 hasAuthorship W2012080421A5087775439 @default.
• W2012080421 hasBestOaLocation W20120804211 @default.
• W2012080421 hasConcept C126322002 @default.
• W2012080421 hasConcept C159047783 @default.
• W2012080421 hasConcept C159654299 @default.
• W2012080421 hasConcept C203014093 @default.
• W2012080421 hasConcept C22070199 @default.
• W2012080421 hasConcept C2776555147 @default.
• W2012080421 hasConcept C2777451964 @default.
• W2012080421 hasConcept C2777625542 @default.
• W2012080421 hasConcept C2777910003 @default.

• next